Smart Pills Market Size, Share & Trends Analysis Report By Indication (Celiac Disease, Small Bowel Diseases, Colon Cancer, Others), By Application (Capsule Endoscopy, Drug Delivery, Vital Sign Monitoring), By End User (Hospitals and Clinics, Diagnostic Centers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 27, 2025 | Author: Debashree B | Format:

Market Segmentation

  1. Smart Pills Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Celiac Disease
    2. Small Bowel Diseases
    3. Colon Cancer
    4. Others
  2. Smart Pills Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Capsule Endoscopy
    2. Drug Delivery
    3. Vital Sign Monitoring
  3. Smart Pills Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals and Clinics
    2. Diagnostic Centers
  4. Regional Smart Pills Market
    1. North America
      1. North America Smart Pills Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
      2. North America Smart Pills Market By Application 2022-2034 (USD MILLION/ Units)
        1. Capsule Endoscopy
        2. Drug Delivery
        3. Vital Sign Monitoring
      3. North America Smart Pills Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Diagnostic Centers
      4. U.S.
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      5. Canada
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
    2. Europe
      1. Europe Smart Pills Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
      2. Europe Smart Pills Market By Application 2022-2034 (USD MILLION/ Units)
        1. Capsule Endoscopy
        2. Drug Delivery
        3. Vital Sign Monitoring
      3. Europe Smart Pills Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Diagnostic Centers
      4. U.K.
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      5. Germany
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      6. France
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      7. Spain
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      8. Italy
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      9. Russia
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      10. Nordic
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      11. Benelux
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      12. Rest of Europe
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
    3. APAC
      1. APAC Smart Pills Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
      2. APAC Smart Pills Market By Application 2022-2034 (USD MILLION/ Units)
        1. Capsule Endoscopy
        2. Drug Delivery
        3. Vital Sign Monitoring
      3. APAC Smart Pills Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Diagnostic Centers
      4. China
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      5. Korea
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      6. Japan
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      7. India
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      8. Australia
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      9. Taiwan
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      10. South East Asia
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      11. Rest of Asia-Pacific
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
    4. Middle East and Africa
      1. Middle East and Africa Smart Pills Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
      2. Middle East and Africa Smart Pills Market By Application 2022-2034 (USD MILLION/ Units)
        1. Capsule Endoscopy
        2. Drug Delivery
        3. Vital Sign Monitoring
      3. Middle East and Africa Smart Pills Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Diagnostic Centers
      4. UAE
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      5. Turkey
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      6. Saudi Arabia
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      7. South Africa
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      8. Egypt
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      9. Nigeria
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      10. Rest of MEA
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
    5. LATAM
      1. LATAM Smart Pills Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
      2. LATAM Smart Pills Market By Application 2022-2034 (USD MILLION/ Units)
        1. Capsule Endoscopy
        2. Drug Delivery
        3. Vital Sign Monitoring
      3. LATAM Smart Pills Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Diagnostic Centers
      4. Brazil
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      5. Mexico
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      6. Argentina
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      7. Chile
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      8. Colombia
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers
      9. Rest of LATAM
        1. Celiac Disease
        2. Small Bowel Diseases
        3. Colon Cancer
        4. Others
        5. Capsule Endoscopy
        6. Drug Delivery
        7. Vital Sign Monitoring
        8. Hospitals and Clinics
        9. Diagnostic Centers

We are featured on: